by John Conrad | Sep 15, 2020 | Policy News
The Illinois Biotechnology Innovation Organization, iBIO, opposes the Trump Administration’s decision to move forward with the flawed concept of a “Most Favored Nation” policy that will dramatically affect most vulnerable seniors and patient communities and...
by John Conrad | Sep 27, 2019 | 2019 Fed Issue, Policy News
On Sept. 19, House Speaker Nancy Pelosi (D-San Francisco) unveiled legislation in the form of the Lower Drug Costs Now Act (H.R. 3) Illinois is home to over 45,000 researchers, doctors, lawyers and business women and men in the biopharma industry who have an...